Megakaryocyte Diversity in Ontogeny, Functions and Cell-Cell Interactions
Authors
Khatib-Massalha, Eman
Méndez-Ferrer, Simón
Publication Date
2022-02-04Journal Title
Frontiers in Oncology
Publisher
Frontiers Media S.A.
Volume
12
Language
en
Type
Other
This Version
VoR
Metadata
Show full item recordCitation
Khatib-Massalha, E., & Méndez-Ferrer, S. (2022). Megakaryocyte Diversity in Ontogeny, Functions and Cell-Cell Interactions. [Other]. https://doi.org/10.3389/fonc.2022.840044
Abstract
Hematopoietic stem cells (HSCs) rely on local interactions in the bone marrow (BM) microenvironment with stromal cells and other hematopoietic cells that facilitate their survival and proliferation, and also regulate their functions. HSCs and multipotent progenitor cells differentiate into lineage-specific progenitors that generate all blood and immune cells. Megakaryocytes (Mks) are hematopoietic cells responsible for producing blood platelets, which are essential for normal hemostasis and blood coagulation. Although the most prominent function of Mks is platelet production (thrombopoiesis), other increasingly recognized functions include HSC maintenance and host immune response. However, whether and how these diverse programs are executed by different Mk subpopulations remains poorly understood. This Perspective summarizes our current understanding of diversity in ontogeny, functions and cell-cell interactions. Cumulative evidence suggests that BM microenvironment dysfunction, partly caused by mutated Mks, can induce or alter the progression of a variety of hematologic malignancies, including myeloproliferative neoplasms (MPNs) and other disorders associated with tissue scarring (fibrosis). Therefore, as an example of the heterogeneous functions of Mks in malignant hematopoiesis, we will discuss the role of Mks in the onset and progression of BM fibrosis. In this regard, abnormal interactions between of Mks and other immune cells might directly contribute to fibrotic diseases. Overall, further understanding of megakaryopoiesis and how Mks interact with HSCs and immune cells has potential clinical implications for stem cell transplantation and other therapies for hematologic malignancies, as well as for treatments to stimulate platelet production and prevent thrombocytopenia.
Keywords
Oncology, megakaryocyte (MK), niche, bone marrow, heterogeneity, hematopoietic stem and progenitor cell (HSPC), emperipolesis, immune
Identifiers
External DOI: https://doi.org/10.3389/fonc.2022.840044
This record's DOI: https://doi.org/10.17863/CAM.81602
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk